Included in general and administrative expenses in our statements of operations included elsewhere in this proxy statement, during the nine months ended September 30, 2020 and 2019 and the years ended December 31, 2019 and 2018, our principal operating expenses included $483,991, $120,610, $189,670 and $3,965, respectively, for the professional, insurance and listing costs associated with our public reporting, $150,000, $150,000, $200,000 and $0, respectively, in franchise taxes, $30,107, $32,828, $38,890 and $2,656, respectively, in consulting and travel costs associated with our search for a business combination candidate and $90,000, $68,065, $98,065 and $0, respectively, in administrative fees to our Sponsor. Further, during the nine months ended September 30, 2020 and 2019 and the years ended December 31, 2019 and 2018, the Company generated $749,420, $3,311,061, $4,472,458 and $0, respectively, of interest income on the U.S. Treasury bills in the Trust Account. During the nine months ended September 30, 2020, the Company generated $154,254 of interest income in the money market funds, meeting certain conditions under Rule 2a-7 under the Investment Company Act which invest only in direct U.S. government obligations, in the Trust Account. Such interest income is currently taxable and results in a provision for income taxes of $210,925 and $665,126 during the nine months ended September 30, 2020 and 2019, respectively, and $1,195,607 and $0 during the years ended December 31, 2019 and 2018, respectively, since the majority of our operating expenses are considered start-up costs and are not currently deductible. The Company will periodically withdraw funds from the Trust Account to fund the payment of income and franchise taxes.
Following the closing of our IPO in March 2019, we have not generated, and will not generate, any operating revenues until after completion of the Business Combination. As discussed above, we currently generate non-operating income in the form of interest income on cash and cash equivalents after our IPO and such income generates a currently payable provision for income taxes on such income since our operating expenses are considered start-up expenses and are not currently deductible. In addition to our taxes, administrative fees to our Sponsor and costs associated with our public reporting, we have increased and will increase expenses for our due diligence and other costs of identifying, documenting and closing the Business Combination and such costs are expected to be very significant and will vary with the stage of development of a business combination. We intend to pay our income and franchise taxes from the income of the Trust Account.
On June 24, 2020, we entered into an Agreement and Plan of Merger (the “F45 Merger Agreement”), by and among us, First Merger Sub, Second Merger Sub, F45 Training Holdings Inc., a Delaware corporation (“F45”), and Shareholder Representative Services LLC, a Colorado limited liability company, which provided for a business combination between us and F45 (the “F45 Business Combination”). Additional information regarding F45 and the F45 Business Combination is available in the proxy statement initially filed with the SEC on July 16, 2020. On October 5, 2020, the Company and F45 entered into a Termination and Release Agreement, effective as of such date, pursuant to which the parties agreed to mutually terminate the F45 Merger Agreement.
Liquidity and Capital Resources
Prior to the completion of our IPO, our liquidity needs were satisfied through receipt of $25,000 from the sale of the Founder Shares to our Sponsor, $300,000 in note payable and $118,323 in advances from an affiliate of the Sponsor.
The net proceeds from (i) the sale of the Units in our IPO, after deducting offering expenses of approximately $900,000 and underwriting commissions of $5,000,000 (excluding deferred underwriting fees of $8,750,000), and (ii) the sale of the Private Placement Warrants for a purchase price of $7,000,000, were approximately $251,100,000. Of this amount, $250,000,000 was placed in the Trust Account, which includes up to $8,750,000 of deferred underwriting fees. The remaining approximately $1,100,000 was available to us for working capital and is not held in the Trust Account.
We intend to use the proceeds from the Forward Purchase Agreement and the PIPE Investment, together with the funds in the Trust Account, and, to the extent the Company’s total cash proceeds are otherwise less than $250,000,000, any proceeds from the sale of additional shares of Class A Stock to Crescent and our Sponsor to
215